1,2-dimethylhydrazine multiple interactions ISO RGD:1321559 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in decreased expression of PRKACB mRNA] CTD PMID:22206623 1,2-dimethylhydrazine decreases expression ISO RGD:1321559 6480464 1, 2-Dimethylhydrazine results in decreased expression of PRKACB mRNA CTD PMID:22206623 17alpha-ethynylestradiol decreases expression ISO RGD:1321559 6480464 Ethinyl Estradiol results in decreased expression of PRKACB mRNA CTD PMID:17555576 17alpha-ethynylestradiol multiple interactions ISO RGD:1321558 6480464 PRKACB protein affects the reaction [Ethinyl Estradiol results in decreased expression of ABCB11 mRNA] more ... CTD PMID:27743861 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of PRKACB mRNA CTD PMID:29097150 17alpha-ethynylestradiol affects expression ISO RGD:1321558 6480464 Ethinyl Estradiol affects the expression of PRKACB mRNA CTD PMID:18936297 17beta-estradiol multiple interactions ISO RGD:1321558 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of PRKACB mRNA CTD PMID:30165855 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one affects expression ISO RGD:1321558 6480464 Metribolone affects the expression of PRKACB mRNA alternative form, Metribolone affects the expression of PRKACB protein alternative form CTD PMID:16949795 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:1321558 6480464 2 more ... CTD PMID:31675489 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1321559 6480464 Tetrachlorodibenzodioxin results in increased expression of PRKACB mRNA CTD PMID:20159946 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PRKACB mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1321559 6480464 Tetrachlorodibenzodioxin affects the expression of PRKACB mRNA CTD PMID:21570461 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of PRKACB mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of PRKACB mRNA CTD PMID:21346803 3',5'-cyclic AMP affects response to substance ISO RGD:1321558 6480464 PRKACB protein mutant form affects the susceptibility to Cyclic AMP CTD PMID:29669941 3',5'-cyclic AMP multiple interactions ISO RGD:1321558 6480464 [PRKACB protein mutant form affects the susceptibility to Cyclic AMP] results in decreased stability of [PRKACB protein mutant form binds to PKIA protein], [PRKACB protein mutant form affects the susceptibility to Cyclic AMP] results in decreased stability of [PRKACB protein mutant form binds to PRKAR1A protein] CTD PMID:29669941 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:1321558 6480464 tetrabromobisphenol A results in decreased expression of PRKACB protein CTD PMID:31675489 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1321559 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of PRKACB mRNA CTD PMID:19285098 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1321558 6480464 [PRKACB protein mutant form results in increased susceptibility to [Colforsin co-treated with 1-Methyl-3-isobutylxanthine]] results in decreased stability of [PRKACB protein mutant form binds to PRKAR1A protein] more ... CTD PMID:29669941 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1, 2-dithiol-3-thione results in decreased expression of PRKACB mRNA CTD PMID:19162173 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of PRKACB mRNA CTD PMID:36041667 4-hydroxyphenyl retinamide increases expression ISO RGD:1321559 6480464 Fenretinide results in increased expression of PRKACB mRNA CTD PMID:28973697 4-vinylcyclohexene dioxide affects expression ISO RGD:1321559 6480464 4-vinyl-1-cyclohexene dioxide affects the expression of PRKACB mRNA CTD PMID:20829426 8-Br-cAMP multiple interactions ISO RGD:1321558 6480464 [PRKACB protein mutant form results in increased susceptibility to 8-Bromo Cyclic Adenosine Monophosphate analog] results in decreased stability of [PRKACB protein mutant form binds to PRKAR1A protein] CTD PMID:29669941 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of PRKACB mRNA CTD PMID:31881176 aflatoxin B1 decreases methylation ISO RGD:1321558 6480464 Aflatoxin B1 results in decreased methylation of PRKACB gene CTD PMID:27153756 all-trans-retinoic acid decreases expression ISO RGD:1321558 6480464 Tretinoin results in decreased expression of PRKACB mRNA CTD PMID:15498508 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of PRKACB mRNA CTD PMID:16483693 androstane-3,17-diol affects expression ISO RGD:1321558 6480464 Androstane-3 more ... CTD PMID:16949795 antirheumatic drug decreases expression ISO RGD:1321558 6480464 Antirheumatic Agents results in decreased expression of PRKACB mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO RGD:1321558 6480464 aristolochic acid I results in decreased expression of PRKACB mRNA CTD PMID:33212167 arsenite(3-) increases expression ISO RGD:1321559 6480464 arsenite results in increased expression of PRKACB mRNA CTD PMID:33053406 benzo[a]pyrene increases mutagenesis ISO RGD:1321558 6480464 Benzo(a)pyrene results in increased mutagenesis of PRKACB gene CTD PMID:25435355 benzo[a]pyrene decreases expression ISO RGD:1321558 6480464 Benzo(a)pyrene results in decreased expression of PRKACB mRNA CTD PMID:20064835 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1321558 6480464 7 more ... CTD PMID:19150397 bis(2-chloroethyl) sulfide increases expression ISO RGD:1321559 6480464 Mustard Gas results in increased expression of PRKACB mRNA CTD PMID:15674844 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PRKACB mRNA CTD PMID:25181051 , PMID:34947998 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of PRKACB mRNA CTD PMID:36041667 bisphenol A decreases expression ISO RGD:1321558 6480464 bisphenol A results in decreased expression of PRKACB protein CTD PMID:31675489 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of PRKACB gene CTD PMID:28505145 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PRKACB mRNA CTD PMID:29097150 Bisphenol B increases expression ISO RGD:1321558 6480464 bisphenol B results in increased expression of PRKACB protein CTD PMID:34186270 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of PRKACB mRNA CTD PMID:36041667 butanal decreases expression ISO RGD:1321558 6480464 butyraldehyde results in decreased expression of PRKACB mRNA CTD PMID:26079696 butanal increases methylation ISO RGD:1321558 6480464 butyraldehyde results in increased methylation of PRKACB gene CTD PMID:30002397 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of PRKACB mRNA CTD PMID:19167457 cannabidiol multiple interactions ISO RGD:1321558 6480464 [PSEN1 protein affects the susceptibility to Cannabidiol] which affects the expression of PRKACB mRNA CTD PMID:33096116 capecitabine decreases response to substance ISO RGD:1321558 6480464 PRKACB protein results in decreased susceptibility to Capecitabine CTD PMID:16734730 carbamazepine affects expression ISO RGD:1321558 6480464 Carbamazepine affects the expression of PRKACB mRNA CTD PMID:24752500 carbon nanotube decreases expression ISO RGD:1321559 6480464 Nanotubes, Carbon results in decreased expression of PRKACB mRNA CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:1321558 6480464 CGP 52608 promotes the reaction [RORA protein binds to PRKACB gene] CTD PMID:28238834 cisplatin decreases expression ISO RGD:1321558 6480464 Cisplatin results in decreased expression of PRKACB mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:1321558 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of PRKACB mRNA CTD PMID:27392435 clozapine decreases expression EXP 6480464 Clozapine results in decreased expression of PRKACB mRNA, Clozapine results in decreased expression of PRKACB protein CTD PMID:11907174 clozapine increases expression EXP 6480464 Clozapine results in increased expression of PRKACB mRNA CTD PMID:15860345 colforsin daropate hydrochloride multiple interactions ISO RGD:1321558 6480464 [PRKACB protein mutant form results in increased susceptibility to [Colforsin co-treated with 1-Methyl-3-isobutylxanthine]] results in decreased stability of [PRKACB protein mutant form binds to PRKAR1A protein] more ... CTD PMID:29669941 coumarin increases phosphorylation ISO RGD:1321558 6480464 coumarin results in increased phosphorylation of PRKACB protein CTD PMID:35688186 coumestrol decreases expression ISO RGD:1321558 6480464 Coumestrol results in decreased expression of PRKACB mRNA CTD PMID:19167446 crocidolite asbestos decreases expression ISO RGD:1321558 6480464 Asbestos, Crocidolite results in decreased expression of PRKACB mRNA CTD PMID:23634900 cyclosporin A increases expression ISO RGD:1321558 6480464 Cyclosporine results in increased expression of PRKACB mRNA CTD PMID:20106945 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of PRKACB mRNA CTD PMID:23914054 deguelin increases expression ISO RGD:1321558 6480464 deguelin results in increased expression of PRKACB mRNA CTD PMID:33512557 dexamethasone decreases phosphorylation EXP 6480464 Dexamethasone results in decreased phosphorylation of PRKACB protein CTD PMID:20032058 dexamethasone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in decreased phosphorylation of PRKACB protein] CTD PMID:20032058 dextran sulfate multiple interactions ISO RGD:1321559 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PRKACB mRNA CTD PMID:29950665 diclofenac affects expression ISO RGD:1321558 6480464 Diclofenac affects the expression of PRKACB mRNA CTD PMID:24752500 diuron increases expression EXP 6480464 Diuron results in increased expression of PRKACB mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:1321558 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxifluridine decreases response to substance ISO RGD:1321558 6480464 PRKACB protein results in decreased susceptibility to doxifluridine CTD PMID:16734730 doxorubicin decreases expression ISO RGD:1321558 6480464 Doxorubicin results in decreased expression of PRKACB mRNA CTD PMID:29803840 entinostat decreases expression ISO RGD:1321558 6480464 entinostat results in decreased expression of PRKACB mRNA CTD PMID:27188386 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of PRKACB mRNA CTD PMID:20655511 ethanol affects splicing ISO RGD:1321559 6480464 Ethanol affects the splicing of PRKACB mRNA CTD PMID:30319688 fipronil increases expression EXP 6480464 fipronil results in increased expression of PRKACB mRNA CTD PMID:34044035 folic acid decreases expression ISO RGD:1321559 6480464 Folic Acid results in decreased expression of PRKACB mRNA CTD PMID:25629700 folic acid multiple interactions ISO RGD:1321559 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in decreased expression of PRKACB mRNA] CTD PMID:22206623 gallic acid decreases expression ISO RGD:1321558 6480464 Gallic Acid results in decreased expression of PRKACB mRNA CTD PMID:34408198 gamma-hexachlorocyclohexane affects expression EXP 6480464 Hexachlorocyclohexane affects the expression of PRKACB mRNA CTD PMID:17785943 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of PRKACB mRNA CTD PMID:22061828 haloperidol increases expression EXP 6480464 Haloperidol results in increased expression of PRKACB mRNA CTD PMID:15860345 heptanal increases methylation ISO RGD:1321558 6480464 heptanal results in increased methylation of PRKACB gene CTD PMID:30002397 hexanal increases methylation ISO RGD:1321558 6480464 n-hexanal results in increased methylation of PRKACB gene CTD PMID:30002397 hydrogen cyanide decreases expression ISO RGD:1321559 6480464 Hydrogen Cyanide results in decreased expression of PRKACB mRNA CTD PMID:33914522 hydrogen sulfide increases expression ISO RGD:1321559 6480464 Hydrogen Sulfide results in increased expression of PRKACB protein CTD PMID:29932956 ivermectin decreases expression ISO RGD:1321558 6480464 Ivermectin results in decreased expression of PRKACB protein CTD PMID:32959892 Kemptide increases phosphorylation ISO RGD:1321558 6480464 PRKACB protein results in increased phosphorylation of kemptide CTD PMID:29669941 lead(0) affects expression ISO RGD:1321558 6480464 Lead affects the expression of PRKACB mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:1321558 6480464 Lead affects the expression of PRKACB mRNA CTD PMID:28903495 lipopolysaccharide increases expression ISO RGD:1321559 6480464 Lipopolysaccharides results in increased expression of PRKACB mRNA CTD PMID:12057914 Methylazoxymethanol acetate increases expression EXP 6480464 Methylazoxymethanol Acetate results in increased expression of PRKACB mRNA CTD PMID:28349193 motexafin gadolinium multiple interactions ISO RGD:1321558 6480464 [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of PRKACB mRNA CTD PMID:16357179 motexafin gadolinium increases expression ISO RGD:1321558 6480464 motexafin gadolinium results in increased expression of PRKACB mRNA CTD PMID:16357179 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of PRKACB gene CTD PMID:33148267 nitrates decreases expression EXP 6480464 Nitrates results in decreased expression of PRKACB mRNA CTD PMID:30022042 nonanal increases methylation ISO RGD:1321558 6480464 nonanal results in increased methylation of PRKACB gene CTD PMID:30002397 octanal increases methylation ISO RGD:1321558 6480464 caprylic aldehyde results in increased methylation of PRKACB gene CTD PMID:30002397 paracetamol affects expression ISO RGD:1321558 6480464 Acetaminophen affects the expression of PRKACB mRNA CTD PMID:25458485 PCB138 affects expression ISO RGD:1321558 6480464 2 more ... CTD PMID:21703328 pentanal decreases expression ISO RGD:1321558 6480464 pentanal results in decreased expression of PRKACB mRNA CTD PMID:26079696 pentanal increases methylation ISO RGD:1321558 6480464 pentanal results in increased methylation of PRKACB gene CTD PMID:30002397 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of PRKACB mRNA CTD PMID:19162173 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of PRKACB gene CTD PMID:33148267 phenylmercury acetate decreases expression ISO RGD:1321558 6480464 Phenylmercuric Acetate results in decreased expression of PRKACB mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1321558 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRKACB mRNA CTD PMID:27188386 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of PRKACB mRNA CTD PMID:19162173 piroxicam decreases expression ISO RGD:1321558 6480464 Piroxicam results in decreased expression of PRKACB mRNA CTD PMID:21858171 propanal increases methylation ISO RGD:1321558 6480464 propionaldehyde results in increased methylation of PRKACB gene CTD PMID:30002397 resveratrol decreases expression ISO RGD:1321559 6480464 resveratrol results in decreased expression of PRKACB mRNA CTD PMID:22610192 SB 431542 multiple interactions ISO RGD:1321558 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sodium fluoride decreases expression ISO RGD:1321559 6480464 Sodium Fluoride results in decreased expression of PRKACB mRNA CTD PMID:21340527 sulindac multiple interactions EXP 6480464 [Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of PRKACB mRNA CTD PMID:20371263 tamibarotene decreases expression ISO RGD:1321558 6480464 tamibarotene results in decreased expression of PRKACB mRNA CTD PMID:15498508 tamoxifen affects expression ISO RGD:1321559 6480464 Tamoxifen affects the expression of PRKACB mRNA CTD PMID:17555576 , PMID:20937368 testosterone decreases expression ISO RGD:1321559 6480464 Testosterone results in decreased expression of PRKACB mRNA CTD PMID:21669218 testosterone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in decreased phosphorylation of PRKACB protein] CTD PMID:20032058 testosterone enanthate affects expression EXP 6480464 testosterone enanthate affects the expression of PRKACB mRNA CTD PMID:25603467 testosterone enanthate affects expression ISO RGD:1321558 6480464 testosterone enanthate affects the expression of PRKACB mRNA CTD PMID:17440010 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of PRKACB mRNA CTD PMID:34492290 titanium dioxide multiple interactions ISO RGD:1321559 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PRKACB mRNA CTD PMID:29950665 torcetrapib increases expression ISO RGD:1321558 6480464 torcetrapib results in increased expression of PRKACB mRNA CTD PMID:23228038 trichostatin A decreases expression ISO RGD:1321558 6480464 trichostatin A results in decreased expression of PRKACB mRNA CTD PMID:22723015 more ... trichostatin A multiple interactions ISO RGD:1321558 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRKACB mRNA CTD PMID:27188386 triclosan increases expression EXP 6480464 Triclosan results in increased expression of PRKACB mRNA CTD PMID:30447264 triptonide increases expression ISO RGD:1321559 6480464 triptonide results in increased expression of PRKACB mRNA CTD PMID:33045310 valproic acid decreases expression ISO RGD:1321559 6480464 Valproic Acid results in decreased expression of PRKACB mRNA CTD PMID:21427059 valproic acid affects methylation ISO RGD:1321558 6480464 Valproic Acid affects the methylation of PRKACB gene CTD PMID:29501571 valproic acid decreases expression ISO RGD:1321558 6480464 Valproic Acid results in decreased expression of PRKACB mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:1321558 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRKACB mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1321558 6480464 Valproic Acid results in increased expression of PRKACB mRNA CTD PMID:29154799 , PMID:29501571 valproic acid affects expression ISO RGD:1321559 6480464 Valproic Acid affects the expression of PRKACB mRNA CTD PMID:17963808 vinclozolin decreases methylation EXP 6480464 vinclozolin results in decreased methylation of PRKACB gene CTD PMID:31079544 vorinostat decreases expression ISO RGD:1321558 6480464 vorinostat results in decreased expression of PRKACB mRNA CTD PMID:27188386 zinc acetate multiple interactions ISO RGD:1321558 6480464 [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of PRKACB mRNA CTD PMID:16357179 zinc acetate increases expression ISO RGD:1321558 6480464 Zinc Acetate results in increased expression of PRKACB mRNA CTD PMID:16357179 zoledronic acid increases expression ISO RGD:1321558 6480464 zoledronic acid results in increased expression of PRKACB mRNA CTD PMID:20977926